These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28813559)

  • 1. Coverage of Intravenous Immunoglobulin for Autoimmune Blistering Diseases Among US Insurers.
    Valdebran M; Amber KT
    JAMA Dermatol; 2017 Nov; 153(11):1189-1190. PubMed ID: 28813559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and treatment of patients with autoimmune bullous disorders in Germany.
    Schmidt E; Zillikens D
    Dermatol Clin; 2011 Oct; 29(4):663-71. PubMed ID: 21925015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders.
    Jolles S
    Clin Exp Immunol; 2002 Sep; 129(3):385-9. PubMed ID: 12197877
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose intravenous immune globulin is also effective in linear IgA disease.
    Kroiss MM; Vogt T; Landthaler M; Stolz W
    Br J Dermatol; 2000 Mar; 142(3):582. PubMed ID: 10777275
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous immunoglobulin G in the treatment of autoimmune bullous disease.
    Czernik A
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):118-9. PubMed ID: 25546786
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of linear IgA disease with salazosulphapyridine and intravenous immunoglobulins.
    Goebeler M; Seitz C; Rose C; Sitaru C; Jeschke R; Marx A; Bröcker EB; Zillikens D
    Br J Dermatol; 2003 Oct; 149(4):912-4. PubMed ID: 14616404
    [No Abstract]   [Full Text] [Related]  

  • 7. What is new in autoimmune vesicobullous disorders?
    Mahajan R; De D
    Indian J Dermatol Venereol Leprol; 2011; 77(4):407-12. PubMed ID: 21727687
    [No Abstract]   [Full Text] [Related]  

  • 8. Will immunoglobulin therapy of autoimmune blistering skin diseases survive the new financial management of inpatients?
    Späth PJ; Hunziker T
    Dermatology; 2011; 222(2):138-9. PubMed ID: 21228555
    [No Abstract]   [Full Text] [Related]  

  • 9. Treating immunobullous diseases: an update.
    Reynaert S; Black MM
    Dermatol Nurs; 2004 Feb; 16(1):29-34, 70. PubMed ID: 15022502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of intravenous immunoglobulin in autoimmune bullous diseases.
    Chee SN; Murrell DF
    Dermatol Clin; 2011 Oct; 29(4):565-70. PubMed ID: 21924999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases.
    Segura S; Iranzo P; Martínez-de Pablo I; Mascaró JM; Alsina M; Herrero J; Herrero C
    J Am Acad Dermatol; 2007 Jun; 56(6):960-7. PubMed ID: 17368865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice and Educational Gaps in Blistering Disease.
    Ehsani-Chimeh N; Marinkovich MP
    Dermatol Clin; 2016 Jul; 34(3):251-6. PubMed ID: 27363880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of autoimmune blistering diseases.
    Levy M; Rico MJ
    Dermatol Clin; 1999 Apr; 17(2):431-40, x. PubMed ID: 10327307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulation of autoimmune and systemic inflammatory diseases with intravenous immunoglobulin.
    Mouthon L; Piketty C; Kazatchkine MD
    Vox Sang; 1994; 67 Suppl 3():53-9. PubMed ID: 7975512
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of intravenous immunoglobulin in autoimmune bullous diseases.
    Chee SN; Murrell DF
    Immunol Allergy Clin North Am; 2012 May; 32(2):323-30, viii. PubMed ID: 22560145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update.
    Czernik A; Toosi S; Bystryn JC; Grando SA
    Autoimmunity; 2012 Feb; 45(1):111-8. PubMed ID: 21923613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of autoimmune bullous diseases: pharmacology and therapeutics.
    Mutasim DF
    J Am Acad Dermatol; 2004 Dec; 51(6):859-77; quiz 878-80. PubMed ID: 15583576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
    Daoud YJ; Amin KG
    Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immune globulin in autoimmune and inflammatory diseases.
    Shimoni Z; Bulvik S; Froom P
    N Engl J Med; 2013 Feb; 368(8):776-7. PubMed ID: 23425182
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous immune globulin in autoimmune and inflammatory diseases.
    Gelfand EW
    N Engl J Med; 2013 Feb; 368(8):777. PubMed ID: 23425181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.